93, question-specific
range [0.84–1.0]). Results 24 PCPs participated in the interviews, including 13 Nurse Practitioners, 6 Physicians, 1 Physician Assistant, and 4 other providers. 30% were located in federally-designated rural areas. Most PCPs perceived selleck kinase inhibitor cirrhosis patients as medically and psychosocially complex. The majority described them in light of severe medical/ psychiatric comorbidities (63%) or clinical management dilemmas (50%), while a notable minority (1 7%) reported challenges in managing patients’ emotional needs and expectations. 83% of PCPs saw their main role in cirrhosis care as monitoring for changes in clinical status (as opposed to directing care), while 54% described their main role as protecting patients from adverse outcomes. Only 20.8% felt comfortable making a diagnosis of cirrhosis without a specialist. Few (12.5%) reported that their own knowledge (or lack) was a barrier to care for ESLD. Conclusions PCPs perceived cirrhosis patients as having very significant medical and
psychosocial challenges. PCPs tended to see themselves not as active drivers of cirrhosis-related management decisions but rather as monitors for disease complications. Few PCPs reported comfort with diagnosing and managing cirrhosis without specialist involvement, yet only a minority saw that as a barrier to care. Educational efforts directed at PCPs must address lack of comfort with cirrhosis management and foster a sense of PCP empowerment. Disclosures: The following people have nothing PF-562271 nmr to disclose: Lauren A. Beste, Bonnie K. Harp, Rebecca K. Blais, Susan Zickmund Purpose: To assess the competence/practice performance of clinicians treating chronic HCV for guiding future educational programs Methods: Although practice self-assessment surveys can be subjective, they may determine gaps in competence/practice
performance. Projects In Knowledge (PIK), a continuing medical education (CME) provider certified by the Accreditation Council for CME (ACCME), implements educational programs in HCV. Online surveys were sent to 6554 clinicians who care for HCV-infected patients, including PIK course participants. Clinicians were asked to self-assess whether they were highly, somewhat, or not at all competent with regard to their knowledge of specific topics, such as HCV risk factors/screening, factors affecting response MCE to treatment, triple therapy and use in difficult-to-treat populations, emerging treatments, and the link between HCV and HCC and/or cirrhosis. In addition, using a four-point scale ranging from always to never, they were asked about the degree to which they perform certain interventions. Results: Of the 272 responses received the first week, 1 70 were from physicians, including 21 hepatologists, 45 gastroenterologists (GIs), 1 6 infectious disease specialists (IDs), 32 internal medicine specialists (IMs), and 56 primary care/family physicians.